Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NASDAQ:DRRX NASDAQ:ITRM NASDAQ:QLI On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeDRRXDURECT$0.63-1.7%$0.61$0.48▼$1.74$19.42M0.6438,912 shs78,476 shsITRMIterum Therapeutics$1.13+4.6%$0.99$0.81▼$3.02$45.20M2.791.08 million shs1.90 million shsQLIQilian International Holding Group$5.41-6.1%$5.45$1.78▼$6.69N/A1.3925,095 shs300 shsInvesting Strategies To Help Grow Your Retirement IncomeNeed to stretch out your 401K or Roth IRA plan? Use these time-tested investing strategies to grow the monthly retirement income that your stock portfolio generates.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceDRRXDURECT0.00%-6.15%-2.23%-16.46%-53.31%ITRMIterum Therapeutics0.00%+18.82%+13.44%+1.80%-23.13%QLIQilian International Holding Group0.00%0.00%0.00%0.00%+24.08%Compare MarketRank™CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & ValuationDRRXDURECT1.5089 of 5 stars0.03.00.04.44.40.00.0ITRMIterum Therapeutics2.077 of 5 stars3.53.00.00.03.30.00.0QLIQilian International Holding GroupN/AN/AN/AN/AN/AN/AN/AN/ACompare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceDRRXDURECT 2.00HoldN/AN/AITRMIterum Therapeutics 3.00Buy$9.00696.46% UpsideQLIQilian International Holding Group 0.00N/AN/AN/ACurrent Analyst Ratings BreakdownLatest ITRM, DRRX, and QLI Analyst RatingsDateCompanyBrokerageActionRatingPrice TargetDetails5/8/2025ITRMIterum TherapeuticsHC WainwrightSubscribe to MarketBeat All Access for the recommendation accuracy ratingReiterated RatingBuy$9.00(Data available from 7/13/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)Compare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookDRRXDURECT$2.03M9.57N/AN/A$0.29 per share2.16ITRMIterum TherapeuticsN/AN/AN/AN/A($0.15) per shareN/AQLIQilian International Holding Group$46.47MN/A$0.32 per share16.80$7.69 per shareN/ACompare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateDRRXDURECT-$8.32M-$0.15N/AN/AN/A-91.54%-267.36%-64.00%8/12/2025 (Estimated)ITRMIterum Therapeutics-$24.77M-$0.99N/A∞N/AN/AN/A-71.37%8/13/2025 (Estimated)QLIQilian International Holding Group-$7.78MN/A0.00∞N/AN/AN/AN/AN/ALatest ITRM, DRRX, and QLI EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails5/13/2025Q1 2025ITRMIterum Therapeutics-$0.14-$0.14N/A-$0.14N/AN/ACompare DividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthDRRXDURECTN/AN/AN/AN/AN/AITRMIterum TherapeuticsN/AN/AN/AN/AN/AQLIQilian International Holding GroupN/AN/AN/AN/AN/ACompare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioDRRXDURECTN/A1.231.22ITRMIterum TherapeuticsN/A3.723.58QLIQilian International Holding GroupN/AN/AN/ACompare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipDRRXDURECT28.03%ITRMIterum Therapeutics9.21%QLIQilian International Holding GroupN/AInsider OwnershipCompanyInsider OwnershipDRRXDURECT3.20%ITRMIterum Therapeutics9.20%QLIQilian International Holding Group58.66%Compare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableDRRXDURECT8031.04 million30.05 millionOptionableITRMIterum Therapeutics1040.00 million36.32 millionNot OptionableQLIQilian International Holding Group280N/AN/ANot OptionableITRM, DRRX, and QLI HeadlinesRecent News About These CompaniesQilian International Holding Group Limited (BGM) - Yahoo FinanceJuly 11 at 6:44 AM | nz.finance.yahoo.comBGM Group Ltd Completes Strategic Acquisition of Wonder Dragon GlobalMay 20, 2025 | tipranks.comBGM Group Expands AI Portfolio with Acquisition of HM ManagementMay 6, 2025 | tipranks.comBGM Group Completes Acquisition of Patriton LimitedMarch 28, 2025 | tipranks.comBGM Group Acquires YX to Boost AI StrategyMarch 19, 2025 | tipranks.comBGM Group Ltd Completes Strategic Acquisition of Patriton LimitedJanuary 7, 2025 | tipranks.comQilian International’s Strategic Transaction and ReorganizationNovember 29, 2024 | tipranks.comQilian International Holding Group Limited Announces Name Change to BGM Group Ltd.October 29, 2024 | finanznachrichten.dePAIYY Aesthetic Medical International Holdings Group LimitedOctober 26, 2024 | seekingalpha.comSITIF SITC International Holdings Company LimitedOctober 26, 2024 | seekingalpha.comSainsbury's biggest investor QIA cuts holdingOctober 11, 2024 | reuters.comALERT: Jinan Hi-tech Holding Group US$ 3yr social IPG 6.1% area, books at US$650m (US$332m)September 26, 2024 | ifre.comIBGM Qilian International Holding Group LimitedSeptember 20, 2024 | seekingalpha.comQilian International Holding Group Ltd Ordinary Shares - Class ASeptember 5, 2024 | morningstar.comMQilian International Holding Group Ltd (BGM)August 29, 2024 | investing.comQilian International Holding Group Ltd. Cl AAugust 15, 2024 | marketwatch.comQilian International Holding Group ltd - Ordinary Shares - Class AAugust 14, 2024 | money.usnews.comQilian International Holding Group Limited (BGM)August 14, 2024 | nz.finance.yahoo.comQilian International Holding Group Ltd. Announces Trading Ticker Symbol to "BGM"August 13, 2024 | prnewswire.com11,000 Global Financial Insurance Elites Converge in Kuala Lumpur. International Dragon Award IDA members share glorious momentsAugust 11, 2024 | msn.comNew MarketBeat Followers Over TimeMedia Sentiment Over TimeITRM, DRRX, and QLI Company DescriptionsDURECT NASDAQ:DRRX$0.63 -0.01 (-1.73%) As of 07/11/2025 04:00 PM EasternDURECT Corporation, a biopharmaceutical company, develops medicines based on its epigenetic regulator program. The company's lead product larsucosterol (DUR-928), an endogenous, orally bioavailable small molecule that is in Phase IIb clinical trial to play a regulatory role in lipid metabolism, stress and inflammatory responses, and cell death and survival to treat alcohol-associated hepatitis, as well as completed Phase Ib clinical trial to treat patients with nonalcoholic steatohepatitis. It also offers ALZET product line that consists of osmotic pumps and accessories used for research in mice, rats, and other laboratory animals. In addition, the company offers POSIMIR, a post-surgical pain product to deliver bupivacaine over three days in adults; and Methydur to treat attention deficit hyperactivity disorder. It markets and sells its ALZET lines through direct sales force in the United States, as well as through a network of distributors in other countries. The company has strategic collaboration and other agreements with Virginia Commonwealth University Intellectual Property Foundation; Indivior UK Ltd.; and Innocoll Pharmaceuticals Limited. DURECT Corporation was incorporated in 1998 and is headquartered in Cupertino, California.Iterum Therapeutics NASDAQ:ITRM$1.13 +0.05 (+4.63%) Closing price 07/11/2025 04:00 PM EasternExtended Trading$1.20 +0.07 (+5.75%) As of 07/11/2025 07:52 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Iterum Therapeutics plc, a clinical-stage pharmaceutical company, engages in developing and commercializing anti-infectives in Ireland, Bermuda, and the United States. It is developing sulopenem, a novel anti-infective compound with oral and intravenous formulations that is in Phase III clinical trials for the treatment of uncomplicated urinary tract infections, complicated urinary tract infections, and complicated intra-abdominal infections. The company was incorporated in 2015 and is headquartered in Dublin, Ireland.Qilian International Holding Group NASDAQ:QLIQilian International Holding Group Limited manufactures and distributes active pharmaceutical ingredients (APIs), traditional Chinese medicine derivatives (TCMD), and other by-products in China. The company provides licorice products, including Gan Di Xin, an antitussive and expectorant medicine; Qilian Shan Licorice Extract, an ingredient for pharmaceutical companies to manufacture traditional licorice tablets; and Qilian Shan licorice liquid extract, a primary ingredient for medical preparation companies to produce compound licorice oral solutions. It offers Qilian Shan oxytetracycline tablets to prevent and treat a range of diseases in chickens, turkeys, cattle, swine, and human; and Qilian Shan oxytetracycline APIs for pharmaceutical companies to manufacture medications. In addition, the company offers TCMD products, such as Ahan antibacterial paste to treat refractory chronic skin diseases; heparin products, including heparin sodium preparations for pharmaceutical companies to produce medications for cardiovascular diseases, cerebrovascular diseases, and hemodialysis; and Zhu Xiaochang sausage casings, which are natural food products for culinary application. Further, it provides Xiongguan organic fertilizers to improve crop yield and soil's chemical properties and reduce soil compaction; and Xiongguan organic-inorganic compound fertilizers to increased plant growth. Qilian International Holding Group Limited was incorporated in 2019 and is based in Jiuquan, the People's Republic of China. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30EcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSocial MediaSolarSpaceTechnologyTelecomToyUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas MarketBeat Week in Review – 07/07 - 07/11 Power Solutions International Poised for 75% Upside The Meteoric Rise of Rocket Lab: A Space Stock to Watch Meta and Autonomous Advertising: The Stock's Next Big Tailwind? 3 Catalysts Converge on Intel Ahead of a Critical Earnings Report Super Micro Computer: The Hidden Winner of Soaring Copper Tariffs Nebius Group: Up 385%, Analysts Say It’s Still a Bargain Conagra at Rock Bottom: 7% Yield & Turnaround Poised Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
